i-RNA Corporation Kicks Off 2026 with Strategic Industry Engagements at OBIO® Investment Summit and ATTD 2026

The i-RNA Corporation team will participate in two key industry events in early 2026.

In February 2026, we will present at the OBIO® Investment Summit in Toronto, a leading forum bringing together Canadian and international investors, life sciences innovators, and ecosystem partners.

In March 2026, our team will be in Barcelona to present and exhibit at ATTD 2026 (Advanced Technologies & Treatments for Diabetes), a leading global conference focused on cutting-edge science and clinical advances in diabetes care and related complications.

We look forward to sharing our work, learning from peers, and contributing to ongoing discussions on innovation in diabetes-related complications and ocular disease.

If you will also be attending either event, we welcome the opportunity to connect. Please feel free to reach out to schedule a meeting with our team.